| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Feature |
University of CaliforniaSan Diego, San Diego, California 92123
Address all correspondence and requests for reprints to: Karen Oerter Klein, M.D., Pediatric Endocrinologist, Childrens Hospital and Health Center, 3020 Childrens WayMC 5103, San Diego, California 92123.
One of the most important issues in womens health concerns the risks and benefits of estrogen replacement therapy. Continual uncertainty and lack of consensus regarding estrogen replacement therapy has driven many women to seek alternative sources of estrogen, including herbal remedies. We adapted a recombinant cell bioassay to measure estrogen bioactivity in herbs. We studied, in vitro, estrogen bioactivity in red clover, dong quai, black cohosh, soy, licorice, chaste tree berry, fo-ti, and hops. Soy, clover, licorice, and hops have a large amount of measurable estrogen bioactivity, as suspected, based on previous reports using other methods. We discovered surprisingly high estrogen activity in extracts of fo-ti not previously reported. Chaste tree berry, black cohosh, and dong quai did not have measurable activity with this method. We also discovered that removal of a glycone group from soy increases its estrogen bioactivity significantly. We conclude that this recombinant cell bioassay for estradiol can be used to measure bioactivity in herbal products. The preparations of fo-ti studied had estrogen activity of 409 ± 55 pmol/liter estradiol equivalents per microgram of herb, which is 1/300th the activity of 17ß-estradiol. Clinical studies are underway to determine the estrogen bioactivity in women using dietary supplements containing these herbs.
This work was supported in part by a gift from Natural Alternatives International.
Abbreviations: ER, Estrogen receptor; SoyA, soy aglycone.
This article has been cited by other articles:
![]() |
A. Cvoro, S. Paruthiyil, J. O. Jones, C. Tzagarakis-Foster, N. J. Clegg, D. Tatomer, R. T. Medina, M. Tagliaferri, F. Schaufele, T. S. Scanlan, et al. Selective Activation of Estrogen Receptor-{beta} Transcriptional Pathways by an Herbal Extract Endocrinology, February 1, 2007; 148(2): 538 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Harris, E. Besselink, S. M. Henning, V. L. W. Go, and D. Heber Phytoestrogens Induce Differential Estrogen Receptor Alpha- or Beta-Mediated Responses in Transfected Breast Cancer Cells Experimental Biology and Medicine, September 1, 2005; 230(8): 558 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Fugate and C. O Church Nonestrogen Treatment Modalities for Vasomotor Symptoms Associated with Menopause Ann. Pharmacother., September 1, 2004; 38(9): 1482 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cho, W. Park, S. Lee, W. Ahn, and Y. Lee Ginsenoside-Rb1 from Panax ginseng C.A. Meyer Activates Estrogen Receptor-{alpha} and -{beta}, Independent of Ligand Binding J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3510 - 3515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |